🔗 Share this article

The Nobel Prize in medical science was granted for transformative findings that illuminate how the body's defense network attacks harmful pathogens while sparing the body's own cells.

A trio of esteemed researchers—Japan's Prof. Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—share this honor.

The research identified unique "sentinels" within the immune system that eliminate rogue immune cells capable of harming the body.

The discoveries are now enabling innovative treatments for immune disorders and cancer.

The laureates will share a prize fund valued at 11 million SEK.

Crucial Discoveries

"Their work has been essential for understanding how the immune system operates and why we don't all suffer from severe autoimmune diseases," commented the head of the award panel.

This team's studies address a core question: How does the defense system defend us from countless infections while keeping our own tissues unharmed?

Our body's protection system uses immune cells that scan for indicators of disease, including viruses and bacteria it has not met before.

These defenders employ detectors—called recognition units—that are produced randomly in a vast number of combinations.

This provides the defense network the capacity to combat a wide array of threats, but the unpredictability of the mechanism unavoidably produces white blood cells that can attack the host.

Protectors of the Body

Researchers previously knew that a portion of these problematic white blood cells were eliminated in the thymus—where immune cells develop.

This year's award recognizes the identification of T-reg cells—known as the immune system's "security guards"—which travel through the body to disarm any defenders that assault the body's own tissues.

We know that this process malfunctions in autoimmune diseases such as type-1 diabetes, MS, and rheumatoid arthritis.

A prize committee added, "These findings have established a novel area of research and accelerated the development of new therapies, for instance for tumors and autoimmune diseases."

In malignancies, T-regs block the system from fighting the tumor, so studies are aimed at lowering their quantity.

For autoimmune diseases, experiments are exploring increasing regulatory T-cells so the body is no longer under attack. A similar approach could also be useful in reducing the chances of organ transplant rejection.

Pioneering Experiments

Prof Sakaguchi, of Osaka University, performed experiments on rodents that had their thymus removed, leading to self-attack conditions.

The researcher showed that injecting immune cells from healthy animals could prevent the illness—suggesting there was a mechanism for blocking defenders from harming the body.

Mary Brunkow, from the Institute for Systems Biology in a US city, and Dr. Ramsdell, now at a biotech firm in a California city, were studying an genetic immune disorder in rodents and people that led to the identification of a genetic factor critical for how T-regs function.

"The pioneering research has revealed how the body's defenses is kept in check by regulatory T cells, preventing it from mistakenly targeting the healthy cells," commented a prominent biological science specialist.

"The research is a remarkable example of how fundamental physiological study can have far-reaching implications for public health."